- Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon
- Author: Mr Mfazo Hove
- Published: May 22, 2025
- Last Updated: July 21, 2026
In short. Blue Fin Vision® provides consultant ophthalmic-led xanthelasma removal in central London at The Harley Street Eye Centre and Weymouth Street Hospital, with a single consultant-led pathway from consultation to aftercare.
Consultant-Led Eyelid Care in Central London
Central London has no shortage of clinics offering to remove eyelid lesions. Xanthelasma sits on the eyelid, so the priority is preserving lid position, margin function and a natural contour, which is where consultant ophthalmic-led care matters most. Most private xanthelasma removal in London is carried out at The Harley Street Eye Centre, our main and most cost-effective setting for this procedure. Weymouth Street Hospital is also available for treatment in a main operating theatre, which adds to the cost and suits patients who need or prefer a hospital-theatre setting. Both are discreet central London locations, convenient for patients travelling into the capital, with the same consultant-led pathway from consultation to aftercare.
Patients visit us from Harley Street, Marylebone, Mayfair, Kensington, Chelsea, St John’s Wood, Hampstead and across Greater London.
What Xanthelasma Is, in Brief
Xanthelasma palpebrarum is a benign, cholesterol-rich plaque on the eyelids that does not usually affect sight¹. It does not mean you definitely have raised cholesterol, but because it can be associated with lipid abnormalities and cardiovascular risk² ³, we advise a lipid check with your GP where appropriate.
Every excision is planned around your eyelid. At Blue Fin Vision®, xanthelasma treatment in London is by surgical excision, carried out under local anaesthetic as a day case, with the plaque carefully excised and the skin closed to protect the eyelid contour⁴. Xanthelasma surgery by excision is recognised in the literature as a mainstay of treatment⁵. Your consultant confirms whether excision is appropriate for your lesions at assessment.
For a fuller explanation of the condition and how it is treated, see our guide to what is xanthelasma?.
Why Blue Fin Vision® in London
You are cared for by Mr Mfazo Hove, in CQC-registered facilities, with a Doctify rating of 4.96 out of 5 from 557+ verified reviews, in a discreet central London setting designed around a single consultant-led pathway.
Frequently Asked Questions
Where in London is treatment carried out?
Most xanthelasma removal in London is at The Harley Street Eye Centre, our most cost-effective setting. Weymouth Street Hospital is available for treatment in a main operating theatre, at additional cost.
Is xanthelasma dangerous?
The plaques are benign, but they can be a marker of cardiovascular risk, so a lipid check is sensible².
Can xanthelasma come back?
Yes, it can recur, especially if cholesterol remains high⁵; no method guarantees permanent removal.
How soon can I return to normal activities?
Most people return to light activities within a few days; any redness or swelling usually settles within about a week.
Does xanthelasma removal improve vision?
Usually no. It is done for appearance and eyelid contour.
Book a consultant-led xanthelasma assessment at Harley Street or Weymouth Street and receive a tailored plan, an exact price, and advice on whether lipid testing is appropriate.
Related Pages
References
- Nair PA, Singhal R. Xanthelasma palpebrarum: a brief review. Clin Cosmet Investig Dermatol. 2018;11:1-5.
- Christoffersen M, Frikke-Schmidt R, Schnohr P, Jensen GB, Nordestgaard BG, Tybjaerg-Hansen A. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. BMJ. 2011;343:d5497.
- Dey A, Aggarwal R, Dwivedi S. Cardiovascular profile of xanthelasma palpebrarum. Biomed Res Int. 2013;2013:932863.
- Lee HY, Jin US, Minn KW, Park YO. Outcomes of surgical management of xanthelasma palpebrarum. Arch Plast Surg. 2013;40(4):380-386.
- Yee DA, Zhou AE, Khachemoune A. Examining treatment strategies for xanthelasma palpebrarum: a comprehensive literature review of contemporary modalities. Arch Dermatol Res. 2024;316(5):149.
ABOUT THE AUTHOR
Mr Mfazo Hove
MBChB MD FRCOphth CertLRS
Consultant Ophthalmic Surgeon | Founder and Medical Director, Blue Fin Vision®
Mr Mfazo Hove is a Consultant Ophthalmic Surgeon with more than two decades of experience across NHS and private practice and more than 57,000 ophthalmic procedures performed. He trained for six and a half years at Moorfields Eye Hospital and served for five years as an NHS consultant at the Western Eye Hospital, Imperial College Healthcare NHS Trust.
He specialises in cataract surgery, refractive lens replacement, laser vision correction and implantable Collamer lenses (ICL). He is the founder and Medical Director of Blue Fin Vision®, a private ophthalmology group providing consultant-delivered care across London, Hertfordshire and Essex. His cataract surgery outcomes are publicly reported through the National Ophthalmology Database.
A ZEISS Key Opinion Leader and international speaker, Mr Hove is a contributing author to The Ophthalmologist. His writing examines how clinical governance and the organisation of ophthalmic services shape patients’ experiences and outcomes, with a focus on transparent outcome reporting, surgical training and long-term accountability for patient care.
